Skip to main content
. 2018 May 30;9:1124. doi: 10.3389/fimmu.2018.01124

Figure 1.

Figure 1

Decreased Siglec-9 expression on NK cells from chronic hepatitis B (CHB) patients. (A) The gating strategy for identification of lymphocytes, CD3 cells, and CD3CD56+ NK cells. (B) The percentage of Siglec-9 expression on CD3CD56dim NK cells and CD3CD56high NK cells from both healthy donors (HDs) and CHB patients. Representative dot plots were shown in left panels. (C) The percentage and mean fluorescence intensity (MFI) of Siglec-9 expression on CD3CD56+ NK cells. (D) The percentage and MFI of Siglec-9 expression on CD3CD56dim NK cells.